Merck, Daiichi reject lung cancer therapy in US (NYSE:MRK)
JHVEPhoto The US Food and Drug Administration (FDA) has refused to approve an antibody-drug conjugate known as HER3-DXd developed by ...
JHVEPhoto The US Food and Drug Administration (FDA) has refused to approve an antibody-drug conjugate known as HER3-DXd developed by ...